[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE493403T1 - Kinaseinhibitoren - Google Patents

Kinaseinhibitoren

Info

Publication number
ATE493403T1
ATE493403T1 AT06826650T AT06826650T ATE493403T1 AT E493403 T1 ATE493403 T1 AT E493403T1 AT 06826650 T AT06826650 T AT 06826650T AT 06826650 T AT06826650 T AT 06826650T AT E493403 T1 ATE493403 T1 AT E493403T1
Authority
AT
Austria
Prior art keywords
kinase inhibitors
kinase
inhibitors
Prior art date
Application number
AT06826650T
Other languages
English (en)
Inventor
Jolie Bastian
De Blas Jesus Blas
Dios Alfonso De
Kevin Hudziak
Tiechao Li
De Uralde-Garmendia Beatriz Lapez
Mary Mader
Michael Myers
Mark Pobanz
Chuan Shih
Boyu Zhong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43298635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE493403(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE493403T1 publication Critical patent/ATE493403T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06826650T 2005-10-28 2006-10-25 Kinaseinhibitoren ATE493403T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73160405P 2005-10-28 2005-10-28
EP06380151 2006-06-02
US82196306P 2006-08-10 2006-08-10
PCT/US2006/041644 WO2007053394A1 (en) 2005-10-28 2006-10-25 Kinase inhibitors

Publications (1)

Publication Number Publication Date
ATE493403T1 true ATE493403T1 (de) 2011-01-15

Family

ID=43298635

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06826650T ATE493403T1 (de) 2005-10-28 2006-10-25 Kinaseinhibitoren

Country Status (19)

Country Link
US (1) US7652015B2 (de)
EP (1) EP1943243B1 (de)
KR (1) KR101004156B1 (de)
AR (1) AR056582A1 (de)
AT (1) ATE493403T1 (de)
AU (1) AU2006309044B2 (de)
BR (1) BRPI0616901A2 (de)
CA (1) CA2627673A1 (de)
DK (1) DK1943243T3 (de)
DO (1) DOP2006000234A (de)
EA (1) EA015189B1 (de)
PE (1) PE20070795A1 (de)
PL (1) PL1943243T3 (de)
PT (1) PT1943243E (de)
RS (1) RS51949B (de)
SI (1) SI1943243T1 (de)
TN (1) TNSN08191A1 (de)
TW (1) TWI325423B (de)
WO (1) WO2007053394A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0905955D0 (en) 2009-04-06 2009-05-20 Respivert Ltd Novel compounds
WO2011124930A1 (en) 2010-04-08 2011-10-13 Respivert Limited P38 map kinase inhibitors
WO2011158044A2 (en) 2010-06-17 2011-12-22 Respivert Limited Respiratory formulations and compounds for use therein
US9029378B2 (en) 2011-07-26 2015-05-12 Gruenenthal Gmbh Substituted bicyclic aromatic carboxamide and urea compounds as vanilloid receptor ligands
US20150225373A1 (en) 2012-08-29 2015-08-13 Respivert Limited Kinase inhibitors
US9783556B2 (en) 2012-08-29 2017-10-10 Respivert Limited Kinase inhibitors
WO2014033446A1 (en) 2012-08-29 2014-03-06 Respivert Limited Kinase inhibitors
US9732063B2 (en) 2012-11-16 2017-08-15 Respivert Limited Kinase inhibitors
EP2981534B1 (de) 2013-04-02 2017-07-19 Topivert Pharma Limited Kinasehemmer auf der basis von n-alkyl-pyrazolen
ES2856902T3 (es) 2013-04-02 2021-09-28 Oxular Acquisitions Ltd Derivados de urea útiles como inhibidores de quinasa
CN106029651A (zh) 2013-12-20 2016-10-12 瑞斯比维特有限公司 用作激酶抑制剂的脲衍生物
PL3113772T3 (pl) 2014-03-07 2021-04-06 Biocryst Pharmaceuticals, Inc. Pirazole podstawiane trifluorometylem jako inhibitory ludzkiej kalikreiny osoczowej
MA40775A (fr) 2014-10-01 2017-08-08 Respivert Ltd Dérivé d'acide 4-(4-(4-phényluréido-naphtalén -1-yl) oxy-pyridin-2-yl) amino-benzoïque utilisé en tant qu'inhibiteur de la kinase p38
CN109071505B (zh) 2016-04-06 2021-11-16 奥苏拉收购有限公司 激酶抑制剂
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
KR20200066655A (ko) 2017-10-05 2020-06-10 풀크럼 쎄러퓨틱스, 인코포레이티드 DUX4의 발현을 저감시키기 위한 p38 저해제의 용도
DK3700902T3 (en) 2017-10-27 2023-05-22 Boehringer Ingelheim Int Inhibitorer af trpc6
AU2021324376A1 (en) 2020-08-13 2023-02-02 Boehringer Ingelheim International Gmbh Treatment of cognitive impairement associated with schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001526222A (ja) * 1997-12-22 2001-12-18 バイエル コーポレイション アリールおよびヘテロアリール置換複素環尿素を使用するｐ３８キナーゼ活性の阻害
ATE400567T1 (de) * 2004-06-23 2008-07-15 Lilly Co Eli Kinaseinhibitoren

Also Published As

Publication number Publication date
US20080269244A1 (en) 2008-10-30
PT1943243E (pt) 2011-01-11
KR101004156B1 (ko) 2010-12-27
PL1943243T3 (pl) 2011-05-31
EP1943243A1 (de) 2008-07-16
AU2006309044A1 (en) 2007-05-10
US7652015B2 (en) 2010-01-26
EP1943243B1 (de) 2010-12-29
TNSN08191A1 (en) 2009-10-30
DOP2006000234A (es) 2007-05-31
AU2006309044B2 (en) 2011-10-13
CA2627673A1 (en) 2007-05-10
PE20070795A1 (es) 2007-08-24
EA015189B1 (ru) 2011-06-30
DK1943243T3 (da) 2011-03-07
SI1943243T1 (sl) 2011-04-29
WO2007053394A1 (en) 2007-05-10
TWI325423B (en) 2010-06-01
EA200801199A1 (ru) 2008-08-29
TW200800184A (en) 2008-01-01
AR056582A1 (es) 2007-10-10
KR20080053394A (ko) 2008-06-12
RS51949B (en) 2012-02-29
BRPI0616901A2 (pt) 2011-07-05

Similar Documents

Publication Publication Date Title
CY2021013I1 (el) Δι-αρυλ μετα-πυριμιδινο αναστολεις κινασων
ATE493403T1 (de) Kinaseinhibitoren
CY2017012I2 (el) Αναστολεις κινασης τυροσινης bruton
DK1979356T3 (da) Carbonylaminopyrrolopyrazoler, kraftige kinaseinhibitorer
DK1704145T3 (da) Selektive kinaseinhibitorer
BRPI0811212A2 (pt) Inibidores de p70 quinase
DK1926722T3 (da) Substituerede benzimidazoler som kinaseinhibitorer
NO20082517L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
BRPI0716781A2 (pt) Inibidores da quinase
IL190078A0 (en) Kinase inhibitors
ATE520671T1 (de) Pyrimidin-harnstoff-derivate als kinase-hemmer
DK2041138T3 (da) Pyrroltriazinkinase-inhibitorer
DK2099447T3 (da) Imidazotriaziner og imidazopyrimidiner som kinaseinhibitorer
DK1940839T3 (da) Pyridopyrimidione Inhibitors of P13Ka
DK2024375T3 (da) Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere
DK1934236T3 (da) Heterobifunktionelle pan-selektininhibitorer
HK1114380A1 (en) Pyrrolopyrazoles as kinase inhibitors
DE602007008837D1 (de) Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
NO20076678L (no) Glutamataggrekanaseinhibitorer
ATE530545T1 (de) Als kinaseinhibitoren geeignete pyrazolylaminopyridinderivate
DK2035385T3 (da) Inhibitorer af akt (proteinkinase B)
DK1856051T3 (da) Amorft lercanidipinhydrochlorid
DK2066662T3 (da) Serinhydrolaseinhibitorer
ATE520664T1 (de) Tyrosinkinase-hemmer
ATE418545T1 (de) Nnrt-inhibitoren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1943243

Country of ref document: EP